Effect of pH and leucine concentration on aerosolization properties of carrier-free formulations of levofloxacin
Authors:
- 1 June 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 118, 13-23
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences & Health Services (94-01-33-28742)
This publication has 48 references indexed in Scilit:
- The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromoleculesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Optimization of anti‐pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolonesPediatric Pulmonology, 2012
- Pulmonary Formulations: What Remains to be Done?Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Formulation strategy and use of excipients in pulmonary drug deliveryInternational Journal of Pharmaceutics, 2010
- Effects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nano-aggregatesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2010
- Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patientsDiagnostic Microbiology and Infectious Disease, 2010
- In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2010
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Bioavailability enhancement of a COX-2 inhibitor, BMS-347070, from a nanocrystalline dispersion prepared by spray-dryingJournal of Pharmaceutical Sciences, 2005
- Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004